| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 578.16 mm | 578.16 mm | 578.16 mm | 578.16 mm | 578.16 mm | 578.16 mm |
| Cash burn (monthly) | (no burn) | 120.67 k | 58.55 mm | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | n/a | 485.35 k | 235.50 mm | n/a | n/a | n/a |
| Cash remaining | n/a | 577.67 mm | 342.66 mm | n/a | n/a | n/a |
| Runway (months of cash) | n/a | 4787.3 | 5.9 | n/a | n/a | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 219 |
| Opened positions | 48 |
| Closed positions | 34 |
| Increased positions | 65 |
| Reduced positions | 68 |
| 13F shares | Current |
|---|---|
| Total value | 1.18 tn |
| Total shares | 274.83 mm |
| Total puts | 19.40 k |
| Total calls | 223.00 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| Maravai Life Sciences Holdings 2 | 130.83 mm | $998.26 mm |
| GTCR | 20.15 mm | $167.45 bn |
| 12 West Capital Management | 14.01 mm | $116.43 bn |
| Vanguard | 11.88 mm | $98.74 bn |
| BlackRock | 10.48 mm | $87.06 bn |
| Braidwell | 8.35 mm | $69.42 bn |
| MKFCF Mackenzie Financial | 6.36 mm | $52.88 bn |
| Millennium Management | 4.33 mm | $35.94 bn |
| Renaissance Technologies | 4.14 mm | $34.39 bn |
| JPM JPMorgan Chase & Co. | 4.05 mm | $33.66 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Jan 25 | Andrew Burch | Class A Common Stock | Payment of exercise | Dispose F | No | No | 4.56 | 54,412 | 248.12 k | 369,183 |
| 15 Jan 25 | Kevin Herde | Class A Common Stock | Payment of exercise | Dispose F | No | No | 4.56 | 46,344 | 211.33 k | 290,256 |
| 15 Jan 25 | Rebecca Buzzeo | Class A Common Stock | Payment of exercise | Dispose F | No | No | 4.56 | 45,456 | 207.28 k | 315,247 |
| 15 Jan 25 | William E. Martin Iii | Class A Common Stock | Payment of exercise | Dispose F | No | No | 4.56 | 160,981 | 734.07 k | 828,449 |
| 15 Jan 25 | Kurt Oreshack | Class A Common Stock | Payment of exercise | Dispose F | No | No | 4.56 | 31,438 | 143.36 k | 192,618 |
